ciprofloxacin has been researched along with Genital Diseases, Female in 19 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Genital Diseases, Female: Pathological processes involving the female reproductive tract (GENITALIA, FEMALE).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To estimate the efficacy of ciprofloxacin in the treatment of pelvic peritonitis, a pharmacokinetic study was conducted in four Japanese subjects." | 7.72 | Pharmacokinetics of single-dose intravenous ciprofloxacin in blood and ascites of patients with pelvic peritonitis. ( Mikamo, H; Ninomiya, M; Tamaya, T, 2003) |
| "To estimate the efficacy of ciprofloxacin in the treatment of pelvic peritonitis, a pharmacokinetic study was conducted in four Japanese subjects." | 3.72 | Pharmacokinetics of single-dose intravenous ciprofloxacin in blood and ascites of patients with pelvic peritonitis. ( Mikamo, H; Ninomiya, M; Tamaya, T, 2003) |
| "Ciprofloxacin was evaluated in chlamydial infections of the urogenital tracts of women treated with a dosage regimen of 500 mg orally twice a day for seven days." | 2.66 | Ciprofloxacin treatment of chlamydial infections of urogenital tracts of women. ( Ahmed-Jushuf, IH; Arya, OP; Hart, CA; Hobson, D; How, SJ; Pratt, BC; Rao, PM; Tait, IA, 1988) |
| "Bacterial vaginosis was present in 32% of the women screened, Chlamydia trachomatis was identified in 8%, none tested positive for Neisseria gonorrhoeae." | 1.32 | Should we offer antibiotic prophylaxis post sexual assault? ( Forster, GE; Gibb, AM; McManus, T, 2003) |
| "Fleroxacin is a potent quinolone with in-vitro activity against a variety of resistant bacterial species." | 1.27 | In-vitro activity of fleroxacin against urinary tract and genital tract pathogens. ( Dubois, J; Fontaine, V, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (47.37) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mustapha, O | 1 |
| Kanj, S | 1 |
| Araj, G | 1 |
| Mroueh, S | 1 |
| Dbeibo, G | 1 |
| Seoud, M | 1 |
| Moodley, P | 1 |
| Martin, IM | 1 |
| Ison, CA | 1 |
| Sturm, AW | 1 |
| Smolyakov, R | 1 |
| Talalay, B | 1 |
| Yanai-Inbar, I | 1 |
| Pak, I | 1 |
| Alkan, M | 1 |
| Gibb, AM | 1 |
| McManus, T | 1 |
| Forster, GE | 1 |
| Mikamo, H | 1 |
| Ninomiya, M | 1 |
| Tamaya, T | 1 |
| Loendersloot, E | 1 |
| Branolte, JH | 1 |
| Weissenhacher, ER | 1 |
| Gotz, A | 1 |
| Braun, H | 1 |
| Gutschow, K | 1 |
| Wachter, I | 1 |
| Roé, E | 1 |
| Barnadas, MA | 1 |
| Bergua, P | 1 |
| Sancho, F | 1 |
| Matas, L | 1 |
| Paredes, R | 1 |
| Pujol, J | 1 |
| Alomar, A | 1 |
| Shopova, E | 1 |
| Matsuda, S | 1 |
| Shimizu, T | 1 |
| Cho, N | 1 |
| Satoh, K | 1 |
| Minaguchi, H | 1 |
| Yagami, Y | 1 |
| Okada, H | 1 |
| Hirabayashi, K | 1 |
| Deguchi, K | 1 |
| Bowie, WR | 2 |
| Willetts, V | 2 |
| Megran, DW | 1 |
| Jewesson, PJ | 1 |
| Childs, SJ | 1 |
| Goldstein, EJ | 1 |
| Newsom, SW | 1 |
| Dubois, J | 1 |
| Fontaine, V | 1 |
| Quentin, R | 1 |
| Koubaa, N | 1 |
| Cattier, B | 1 |
| Gavignet, M | 1 |
| Goudeau, A | 1 |
| Ahmed-Jushuf, IH | 1 |
| Arya, OP | 1 |
| Hobson, D | 1 |
| Pratt, BC | 1 |
| Hart, CA | 1 |
| How, SJ | 1 |
| Tait, IA | 1 |
| Rao, PM | 1 |
2 reviews available for ciprofloxacin and Genital Diseases, Female
| Article | Year |
|---|---|
Enterobius vermicularis infection of female genital tract: a report of three cases and review of literature.
Topics: Abdominal Pain; Adult; Ciprofloxacin; Enterobiasis; Fallopian Tube Diseases; Fallopian Tubes; Female | 2003 |
Ciprofloxacin as treatment for genitourinary tract infection.
Topics: Bacterial Infections; Ciprofloxacin; Female; Genital Diseases, Female; Genital Diseases, Male; Human | 1989 |
3 trials available for ciprofloxacin and Genital Diseases, Female
| Article | Year |
|---|---|
Dose-ranging study of fleroxacin for treatment of uncomplicated Chlamydia trachomatis genital infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Ciprofl | 1989 |
Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Drug Interaction | 1989 |
Ciprofloxacin treatment of chlamydial infections of urogenital tracts of women.
Topics: Chlamydia Infections; Ciprofloxacin; Clinical Trials as Topic; Female; Genital Diseases, Female; Gon | 1988 |
14 other studies available for ciprofloxacin and Genital Diseases, Female
| Article | Year |
|---|---|
Genital ulceration associated with typhoid fever.
Topics: Adolescent; Anti-Infective Agents; Biopsy; Ciprofloxacin; Female; Genital Diseases, Female; Humans; | 2009 |
Typing of Neisseria gonorrhoeae reveals rapid reinfection in rural South Africa.
Topics: Adolescent; Adult; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Bacterial Typing Techni | 2002 |
Should we offer antibiotic prophylaxis post sexual assault?
Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Chlamydia t | 2003 |
Pharmacokinetics of single-dose intravenous ciprofloxacin in blood and ascites of patients with pelvic peritonitis.
Topics: Anti-Infective Agents; Ascitic Fluid; Ciprofloxacin; Escherichia coli; Female; Genital Diseases, Fem | 2003 |
Efficacy and safety of ciprofloxacin in gynaecological infections.
Topics: Acute Disease; Administration, Oral; Anti-Infective Agents; Bacterial Infections; Chronic Disease; C | 1989 |
Treatment of soft tissue infections in gynecology by comparison 3 vs 7 day therapy with ciprofloxacin.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Clinical Trials as Topic; Drug Administration Schedule; | 1989 |
Ano-genital granulomatosis treated with ciprofloxacin.
Topics: Adult; Anti-Infective Agents; Anus Diseases; Ciprofloxacin; Female; Genital Diseases, Female; Granul | 2009 |
[The appearance of ciprofloxacin resistance in the microbial strains isolated from gynecologic patients].
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Female; Genital Diseases, Female; | 1997 |
National guideline for the management of donovanosis (granuloma inguinale). Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Contraindications; Doxycycline; Female; Genital | 1999 |
National guideline for the management of chancroid. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Azithromycin; Breast Feeding; Ceftriaxone; Chancroid; Ciprofloxacin; Contrain | 1999 |
[Clinical evaluation of fleroxacin in gynecological infections].
Topics: Administration, Oral; Adolescent; Adult; Bacteria; Bacterial Infections; Ciprofloxacin; Drug Evaluat | 1991 |
The clinical use of quinolones.
Topics: Ciprofloxacin; Escherichia coli; Feces; Female; Genital Diseases, Female; Genital Diseases, Male; Hu | 1986 |
In-vitro activity of fleroxacin against urinary tract and genital tract pathogens.
Topics: Ampicillin; Anti-Infective Agents; Bacteria; Ciprofloxacin; Female; Fleroxacin; Genital Diseases, Fe | 1988 |
In vitro activities of five new quinolones against 88 genital and neonatal Haemophilus isolates.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Enoxacin; Female; Genital Diseases, Female; Genital Diseases, | 1988 |